Emcure, Gennova settle litigation with HDT, ink pact to develop mRNAvaccines
Under the settlement, the litigation between them, including before US courts and the arbitral tribunal in London, has been settled and dismissed, Emcure said in a statement.
Emcure Pharmaceuticals Ltd and its arm Gennova Biopharmaceuticals have settled all legal disputes with HDT Bio Corp and have signed a long-term agreement to develop mRNA vaccines, the company said on Thursday.
Under the settlement, the litigation between them, including before US courts and the arbitral tribunal in London, has been settled and dismissed, Emcure said in a statement.
The parties have also entered into a long-term agreement to develop mRNA vaccines against a broad range of infectious diseases, in India and several other countries. As part of their agreement, HDT has granted a licence to Gennova to use its patented mRNA vaccine technology in multiple fields, it added.
"Gennova and HDT, who previously collaborated on the successful development of Gennova's mRNA Covid-19 vaccines, will once again collaborate on the development and commercialisation of mRNA vaccines," the statement said.
HDT had filed lawsuit against Emcure alleging stealing of Covid-19 vaccine technology trade secrets.
Emcure Pharmaceuticals CEO & Managing Director Satish Mehta said,"...The misunderstanding between us and HDT not only stands resolved but we have widened the scope of our technical collaboration on a long-term basis." He further said,"mRNA platform will be the launching pad for our foray into vaccines for tuberculosis, rabies, dengue and other infectious diseases and our collaboration with HDT will be mutually beneficial."
Commenting on the development, HDT CEO Steve Reed said,"HDT's proprietary technology, combined with Emcure's and Gennova's innovation and manufacturing excellence and established distribution network will bring life-saving vaccines to countless people. We are committed to a successful relationship with Emcure and Gennova."
Catch all the updates of the May 23 session on Dalal Street here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
CBI searches 14 locations in connection with alleged Rs 5,717-crore bank fraud by SKS Power Generation: Report
Post Office Scheme for Senior Citizens: How much quarterly amount will you get on Rs 5 lakh, Rs 10 lakh, Rs 15 lakh and Rs 20 lakh investments
Online Scam: Mumbai's software engineer loses Rs 5.14 crore in share trading fraud, tuition teacher and security guard arrested
Top 5 ELSS SIP mutual funds in 3 years: Know current values of Rs 5,000, Rs 10,000, and Rs 15,000 monthly SIPs in each fund
Bakra Eid Bakrid bank holiday on Monday in June 17 2024 full list Eid al-Adha long weekend in jammu srinagar
01:31 PM IST